127 related articles for article (PubMed ID: 11101143)
1. Characterization of mutant HIV-1 integrase carrying amino acid changes in the catalytic domain.
Sayasith K; Sauvé G; Yelle J
Mol Cells; 2000 Oct; 10(5):525-32. PubMed ID: 11101143
[TBL] [Abstract][Full Text] [Related]
2. Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity.
Zheng R; Jenkins TM; Craigie R
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13659-64. PubMed ID: 8942990
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the human spuma retrovirus integrase by site-directed mutagenesis, by complementation analysis, and by swapping the zinc finger domain of HIV-1.
Pahl A; Flügel RM
J Biol Chem; 1995 Feb; 270(7):2957-66. PubMed ID: 7852375
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and random mutagenesis analysis of the region carrying the catalytic E152 amino acid of HIV-1 integrase.
Calmels C; de Soultrait VR; Caumont A; Desjobert C; Faure A; Fournier M; Tarrago-Litvak L; Parissi V
Nucleic Acids Res; 2004; 32(4):1527-38. PubMed ID: 14999095
[TBL] [Abstract][Full Text] [Related]
5. Characterization of human immunodeficiency virus type 1 integrase mutants expressed in Escherichia coli.
Oh JW; Oh YT; Kim DJ; Shin CG
Mol Cells; 1997 Oct; 7(5):688-93. PubMed ID: 9387159
[TBL] [Abstract][Full Text] [Related]
6. Selection of amino acid substitutions restoring activity of HIV-1 integrase mutated in its catalytic site using the yeast Saccharomyces cerevisiae.
Parissi V; Caumont AB; de Soultrait VR; Calmels C; Pichuantes S; Litvak S; Dupont CH
J Mol Biol; 2000 Jan; 295(4):755-65. PubMed ID: 10656788
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations.
Vincent KA; Ellison V; Chow SA; Brown PO
J Virol; 1993 Jan; 67(1):425-37. PubMed ID: 8416376
[TBL] [Abstract][Full Text] [Related]
8. Metal-dependent inhibition of HIV-1 integrase by beta-diketo acids and resistance of the soluble double-mutant (F185K/C280S).
Marchand C; Johnson AA; Karki RG; Pais GC; Zhang X; Cowansage K; Patel TA; Nicklaus MC; Burke TR; Pommier Y
Mol Pharmacol; 2003 Sep; 64(3):600-9. PubMed ID: 12920196
[TBL] [Abstract][Full Text] [Related]
9. Effects of mutations in residues near the active site of human immunodeficiency virus type 1 integrase on specific enzyme-substrate interactions.
Gerton JL; Ohgi S; Olsen M; DeRisi J; Brown PO
J Virol; 1998 Jun; 72(6):5046-55. PubMed ID: 9573274
[TBL] [Abstract][Full Text] [Related]
10. Abasic site recognition mechanism by the Escherichia coli exonuclease III.
Shida T; Kaneda K; Ogawa T; Sekiguchi J
Nucleic Acids Symp Ser; 1999; (42):195-6. PubMed ID: 10780446
[TBL] [Abstract][Full Text] [Related]
11. Reversion of a human immunodeficiency virus type 1 integrase mutant at a second site restores enzyme function and virus infectivity.
Taddeo B; Carlini F; Verani P; Engelman A
J Virol; 1996 Dec; 70(12):8277-84. PubMed ID: 8970947
[TBL] [Abstract][Full Text] [Related]
12. Site-directed mutagenesis of HIV-1 integrase demonstrates differential effects on integrase functions in vitro.
Leavitt AD; Shiue L; Varmus HE
J Biol Chem; 1993 Jan; 268(3):2113-9. PubMed ID: 8420982
[TBL] [Abstract][Full Text] [Related]
13. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain.
Masuda T; Planelles V; Krogstad P; Chen IS
J Virol; 1995 Nov; 69(11):6687-96. PubMed ID: 7474078
[TBL] [Abstract][Full Text] [Related]
14. Identification of a nucleotide binding site in HIV-1 integrase.
Drake RR; Neamati N; Hong H; Pilon AA; Sunthankar P; Hume SD; Milne GW; Pommier Y
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4170-5. PubMed ID: 9539708
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus type 1 integrase: arrangement of protein domains in active cDNA complexes.
Gao K; Butler SL; Bushman F
EMBO J; 2001 Jul; 20(13):3565-76. PubMed ID: 11432843
[TBL] [Abstract][Full Text] [Related]
16. The catalytic domain of human immunodeficiency virus integrase: ordered active site in the F185H mutant.
Bujacz G; Alexandratos J; Qing ZL; Clément-Mella C; Wlodawer A
FEBS Lett; 1996 Dec; 398(2-3):175-8. PubMed ID: 8977101
[TBL] [Abstract][Full Text] [Related]
17. A soluble active mutant of HIV-1 integrase: involvement of both the core and carboxyl-terminal domains in multimerization.
Jenkins TM; Engelman A; Ghirlando R; Craigie R
J Biol Chem; 1996 Mar; 271(13):7712-8. PubMed ID: 8631811
[TBL] [Abstract][Full Text] [Related]
18. Catalytic domain of human immunodeficiency virus type 1 integrase: identification of a soluble mutant by systematic replacement of hydrophobic residues.
Jenkins TM; Hickman AB; Dyda F; Ghirlando R; Davies DR; Craigie R
Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6057-61. PubMed ID: 7597080
[TBL] [Abstract][Full Text] [Related]
19. Characterization of HIV-1 integrase interaction with human Ku70 protein and initial implications for drug targeting.
Anisenko AN; Knyazhanskaya ES; Zalevsky AO; Agapkina JY; Sizov AI; Zatsepin TS; Gottikh MB
Sci Rep; 2017 Jul; 7(1):5649. PubMed ID: 28717247
[TBL] [Abstract][Full Text] [Related]
20. Real-time monitoring of disintegration activity of catalytic core domain of HIV-1 integrase using molecular beacon.
Zhang DW; Zhao MM; He HQ; Guo SX
Anal Biochem; 2013 Sep; 440(2):120-2. PubMed ID: 23747532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
